We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Middleware Boosts Efficiency in Lab Automation

By LabMedica International staff writers
Posted on 03 May 2012
New middleware for clinical chemistry, microbiology, and molecular biology labs improves laboratory efficiency, compliance, and quality control.

Dubbed Halia, the middleware utilizes a rule-based engine to deliver all-round control over laboratory workflow, and sample processing. More...
The new interface provides a complete web-based lab computerization system, allowing central management and connection of all analyzers through a single interface on any workstation.

Halia’s user-configurable rule-based engine enables autoverification, sample routing, and real-time clinical data capture and management for greater quality control. By supporting open automation systems and addressing issues such as regulatory compliance, workforce reductions, and enhanced quality control, Halia effectively meets the challenges facing lab managers.

Halia instrument middleware from NoemaLife (Bologna, Italy), a European provider of clinical and hospital software solutions, provides a complete lab computerization solution. Halia also provides detailed real-time data on total turnaround time (TAT)–a key performance indicator in large laboratories striving to increase throughput. Halia permits central management of all the pre-analysis, analysis, and post analysis instruments found in a modern clinical lab.

If a Laboratory Information System/Laboratory Information Management System (LIS/LIMS system) goes down, Halia’s LIS/LIMS backup module allows manual input of sample information so that analysis can continue. Manual samples are then matched to LIS/LIMS data once the connection is restored.

Andrea Chiapponi, managing director of NoemaLife SpA, commented, "In addition to laboratories looking for open middleware which is vendor independent, Halia will be of interest to IVD device vendors wanting to create turnkey solutions which include maximum LIS/LIMS connectivity. Halia’s vendor-independence also enables merging of laboratories and even hospitalswith different LIS/LIMS solutions into a seamless wide area network. For example, Halia can manage re-tests on different analyzers deployed in separate labs and coordinate specimen storage information relating to multiple locations."

Related Links:
NoemaLife



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Immunofluorescence Analyzer
IFA System
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.